213 related articles for article (PubMed ID: 28771231)
21. Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.
Srivastava SP; Goodwin JE; Kanasaki K; Koya D
Br J Pharmacol; 2020 Aug; 177(16):3691-3711. PubMed ID: 32352559
[TBL] [Abstract][Full Text] [Related]
22. N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects.
Kanasaki K
J Diabetes Investig; 2020 May; 11(3):516-526. PubMed ID: 31997585
[TBL] [Abstract][Full Text] [Related]
23. Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen.
Nitta K; Shi S; Nagai T; Kanasaki M; Kitada M; Srivastava SP; Haneda M; Kanasaki K; Koya D
Biomed Res Int; 2016; 2016():9172157. PubMed ID: 27088094
[TBL] [Abstract][Full Text] [Related]
24. Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
Shi S; Srivastava SP; Kanasaki M; He J; Kitada M; Nagai T; Nitta K; Takagi S; Kanasaki K; Koya D
Kidney Int; 2015 Sep; 88(3):479-89. PubMed ID: 25830763
[TBL] [Abstract][Full Text] [Related]
25. N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m
Wei A; Zhao F; Hao A; Liu B; Liu Z
Gene; 2022 Mar; 813():146125. PubMed ID: 34921949
[TBL] [Abstract][Full Text] [Related]
26. [Role of extracellular signal-regulated kinase 1/2 on inhibition of N-acetyl-seryl-aspartyl-lysyl-proline on proliferation and collagen synthesis of cultured rat pulmonary fibroblasts induced by platelet-derived growth factor].
Wu KF; Fang Y; Li DD; Zhang LJ; Li Q; Wang RM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2009 Jul; 27(7):385-9. PubMed ID: 20039534
[TBL] [Abstract][Full Text] [Related]
27. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
[TBL] [Abstract][Full Text] [Related]
28. N-Acetyl-seryl-aspartyl-lysyl-proline inhibits TGF-beta-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells.
Kanasaki K; Koya D; Sugimoto T; Isono M; Kashiwagi A; Haneda M
J Am Soc Nephrol; 2003 Apr; 14(4):863-72. PubMed ID: 12660320
[TBL] [Abstract][Full Text] [Related]
29. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
[TBL] [Abstract][Full Text] [Related]
30. MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer.
Huang H; Han Q; Zheng H; Liu M; Shi S; Zhang T; Yang X; Li Z; Xu Q; Guo H; Lu F; Wang J
Cell Death Dis; 2021 Dec; 13(1):13. PubMed ID: 34930918
[TBL] [Abstract][Full Text] [Related]
31. [Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline mediated by regulation of transforming growth factor beta and connective tissue growth factor expression on rats with silicosis].
Li Q; Yang F; Zhang LJ; Yan JB; Chen P; Li DD; Wu KF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2009 Jul; 27(7):390-4. PubMed ID: 20039536
[TBL] [Abstract][Full Text] [Related]
32. A dual role of YAP in driving TGFβ-mediated endothelial-to-mesenchymal transition.
Savorani C; Malinverno M; Seccia R; Maderna C; Giannotta M; Terreran L; Mastrapasqua E; Campaner S; Dejana E; Giampietro C
J Cell Sci; 2021 Aug; 134(15):. PubMed ID: 34338295
[TBL] [Abstract][Full Text] [Related]
33. Semaphorin 7A promotes endothelial to mesenchymal transition through ATF3 mediated TGF-β2/Smad signaling.
Hong L; Li F; Tang C; Li L; Sun L; Li X; Zhu L
Cell Death Dis; 2020 Aug; 11(8):695. PubMed ID: 32826874
[TBL] [Abstract][Full Text] [Related]
34. MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
Vitorino P; Yeung S; Crow A; Bakke J; Smyczek T; West K; McNamara E; Eastham-Anderson J; Gould S; Harris SF; Ndubaku C; Ye W
Nature; 2015 Mar; 519(7544):425-30. PubMed ID: 25799996
[TBL] [Abstract][Full Text] [Related]
35. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
36. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.
Park JS; Choi HI; Kim DH; Kim CS; Bae EH; Ma SK; Kim SW
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690042
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells.
Mahler GJ; Farrar EJ; Butcher JT
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):121-30. PubMed ID: 23104848
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer.
Tomlinson DC; Lamont FR; Shnyder SD; Knowles MA
Cancer Res; 2009 Jun; 69(11):4613-20. PubMed ID: 19458078
[TBL] [Abstract][Full Text] [Related]
39. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
[TBL] [Abstract][Full Text] [Related]
40. Fibronectin induces endothelial cell migration through β1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653/654 and 766.
Zou L; Cao S; Kang N; Huebert RC; Shah VH
J Biol Chem; 2012 Mar; 287(10):7190-202. PubMed ID: 22247553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
